A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
Michael D. Miller, Antonello Pessi, Paolo Ingallinella, John W. Shiver(IGM Biosciences (United States)), Christopher Lloyd, Hangchun Zhang, Emilio A. Emini(United States Military Academy), Zhiqiang An(Brown Foundation), Michael McElhaugh, William A. Schleif, Marco Mattu, Joseph G. Joyce(United States Military Academy), Meiqing Lu, William R. Strohl(Cook Biotech (United States)), Tristan J. Vaughan, Gennaro Ciliberto(Tumori Foundation), Simon Lennard, David Bramhill(Stanford University), Debra M. Eckert(University of Utah), Adam C. Finnefrock(United States Military Academy), Elisabetta Bianchi(IRBM Science Park), Jane Osbourn, Romas Geleziunas(Gilead Sciences (United States)), Steven Lane(University of Liverpool), Gaetano Barbato, Marco Finotto, Renee Hrin, Daria J. Hazuda(United States Military Academy), David C. Lowe, Peter S. Kim(Stanford Medicine), Ping Lu(First Affiliated Hospital of Xinxiang Medical University), Riccardo Cortese(Sigma Tau (Italy)), Stephen Jarantow, James C. Cook(United States Military Academy), Richard Hampton
Cited by 156
Related Papers
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
|Science|1993|2.3k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
|BioDrugs|2017|1.3k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k